¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2024 Àç°ü·ùÄ¡·á¿¬±¸È¸ Ãá°è½ÉÆ÷Áö¿ò ¹× ÃÑȸ : 2024-07-13

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2024 Àç°ü·ùÄ¡·á¿¬±¸È¸ Ãá°è½ÉÆ÷Áö¿ò ¹× ÃÑȸ : 2024-07-13
±³À°ÀÏÀÚ : 2024-07-13
±³À°Àå¼Ò : ¹é¹ü±â³ä°ü ÄÁº¥¼ÇȦ

±³À°ÁÖÁ¦ : 2024 Àç°ü·ùÄ¡·á¿¬±¸È¸ Ãá°è½ÉÆ÷Áö¿ò ¹× ÃÑȸ

ÁÖÃÖ±â°ü : ´ëÇѳúÁ¹ÁßÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Àç°ü·ùÄ¡·á¿¬±¸È¸

´ã´çÀÚ : Àç°ü·ùÄ¡·á¿¬±¸È¸
¿¬¶ôó : 02-2228-1614

À̸ÞÀÏ : reperfusion119@gmail.com

±³À°Á¾·ù : ½Å°æ¿Ü°ú, ¿µ»óÀÇÇаú, ½Å°æ°ú, ÀçÈ°ÀÇÇаú

Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 3Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 4 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 20,000¿ø  

ºñ°í ȸ¿ø 1¸¸¿ø, ºñȸ¿ø 2¸¸¿ø(Àü°øÀÇ ¹«·á)


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 07¿ù 13ÀÏ ¹é¹ü±â³ä°ü ÄÁº¥¼ÇȦ 09:00~09:20 Recent researches in endovascular treatment ±ÇµÎÇõ(¿µ³²´ëº´¿ø ½Å°æ°ú)

±³À°½Ã°£ 07¿ù 13ÀÏ ¹é¹ü±â³ä°ü ÄÁº¥¼ÇȦ 09:20~09:40 Machine learning and artificial intelligence-based approach in reperfusion treatment ÇãÁسç(Á߾Ӵ뱤¸íº´¿ø ½Å°æ°ú)

±³À°½Ã°£ 07¿ù 13ÀÏ ¹é¹ü±â³ä°ü ÄÁº¥¼ÇȦ 09:40~10:00 New devices and techniques in endovascular treatment °ûÈ¿¼º(ÀüºÏ´ëº´¿ø ¿µ»óÀÇÇаú)

Åä·Ð 07¿ù 13ÀÏ ¹é¹ü±â³ä°ü ÄÁº¥¼ÇȦ 10:00~10:10 QnA ( )

ÈÞ½Ä 07¿ù 13ÀÏ ¹é¹ü±â³ä°ü ÄÁº¥¼ÇȦ 10:10~10:20 Coffee Break ( )

±³À°½Ã°£ 07¿ù 13ÀÏ ¹é¹ü±â³ä°ü ÄÁº¥¼ÇȦ 10:20~10:40 Utility of thrombus characteristics in intravenous thrombolysis ¹ÚÇüÁ¾(°è¸í´ëµ¿»êº´¿ø ½Å°æ°ú)

±³À°½Ã°£ 07¿ù 13ÀÏ ¹é¹ü±â³ä°ü ÄÁº¥¼ÇȦ 10:40~11:00 Radiological and histological characteristics of thrombus in endovascular treatment ¹éÀåÇö(°­ºÏ»ï¼ºº´¿ø ½Å°æ°ú)

±³À°½Ã°£ 07¿ù 13ÀÏ ¹é¹ü±â³ä°ü ÄÁº¥¼ÇȦ 11:00~11:20 Applicability of hemostasis or coagulation assay in stroke management ¼ÛÅÂÁø(ÀÌ´ë¼­¿ïº´¿ø ½Å°æ°ú)

Åä·Ð 07¿ù 13ÀÏ ¹é¹ü±â³ä°ü ÄÁº¥¼ÇȦ 11:20~11:30 QnA ( )

±âŸ 07¿ù 13ÀÏ ¹é¹ü±â³ä°ü ÄÁº¥¼ÇȦ 11:30~11:45 ÃÑȸ ( )

½Ä»ç 07¿ù 13ÀÏ ¹é¹ü±â³ä°ü ÄÁº¥¼ÇȦ 11:45~13:00 Lunch ( )

±³À°½Ã°£ 07¿ù 13ÀÏ ¹é¹ü±â³ä°ü ÄÁº¥¼ÇȦ 13:00~13:20 Tenecteplase vs. alteplase: Evaluating superiority ¿ìÈ£°É(°æÈñ´ëº´¿ø ½Å°æ°ú)

±³À°½Ã°£ 07¿ù 13ÀÏ ¹é¹ü±â³ä°ü ÄÁº¥¼ÇȦ 13:20~13:40 Usefulness of tenecteplase in various conditions: Extended time window and endovascular treatment ¹é¹Î·Ä(¿ëÀμ¼ºê¶õ½ºº´¿ø ½Å°æ°ú)

Åä·Ð 07¿ù 13ÀÏ ¹é¹ü±â³ä°ü ÄÁº¥¼ÇȦ 13:40~13:50 QnA ( )

±³À°½Ã°£ 07¿ù 13ÀÏ ¹é¹ü±â³ä°ü ÄÁº¥¼ÇȦ 13:50~14:05 Current global recommendations for door-to-puncture time ±èº¸±Ô(°í´ë¾È¾Ïº´¿ø ¿µ»óÀÇÇаú)

±³À°½Ã°£ 07¿ù 13ÀÏ ¹é¹ü±â³ä°ü ÄÁº¥¼ÇȦ 14:05~14:20 Current status of door-to-puncture time in Korea: Realities and challenges ÀÌÁ¤À±(¼øõÇâ¼­¿ïº´¿ø ½Å°æ°ú)

Åä·Ð 07¿ù 13ÀÏ ¹é¹ü±â³ä°ü ÄÁº¥¼ÇȦ 14:20~14:40 Panel discussion ±èÁØÈÖ Á¤¿ì»ó ¼­Á¤È­ ¹ÚÁ¤Áø(¿ëÀμ¼ºê¶õ½ºº´¿ø ¾ÆÁִ뺴¿ø ºÎ»ê¹éº´¿ø °Ç±¹´ëº´¿ø)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2024 Àç°ü·ùÄ¡·á¿¬±¸È¸ Ãá°è½ÉÆ÷Áö¿ò ¹× ÃÑȸ : 2024-07-13""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û õ½Ä¿¬±¸È¸ Workshop 2024 : 2024-07-13
´ÙÀ½±Û Çѱ¹¹é³»Àå±¼Àý¼ö¼úÇÐȸ 2024 KSCRS Annual Symposium(1ÀÏÂ÷) : 2024-07-13
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
452 ¼­¿ï ´ëÇÑÁ¤ÇüÅëÁõÀÇÇÐȸ Á¦ 16ȸ Ãß°ÔÇмú´ëȸ : 2018-08-26 0 1,081 2018-08-22
451 ¼­¿ï Çѱ¹ÀÇÇй°¸®ÇÐȸ 2018 ¿©¸§ ÀÇÇй°¸®½ÉÈ­±³À° 2 : 2018-08-25 0 414 2018-08-22
450 ºÎ»ê µ¿¾Æ´ëÇб³ÀÇ·á¿ø ÀÓ»ó ¿µ¿ª¿¡¼­ ´Ù¾çÇÑ ÁßÀçÄ¡·á½Ã¼úÀÇ ÇöÀç¿Í ¹Ì·¡ : 2018-08-25 0 530 2018-08-22
449 °æ±â 2018³â ´ëÇѱٰ¨¼ÒÁõÇÐȸ Á¦6Â÷ Çмú´ëȸ : 2018-08-25 0 492 2018-08-22
448 ¼­¿ï Çѱ¹ÀÇÇй°¸®ÇÐȸ 2018 ¿©¸§ ÀÇÇй°¸®½ÉÈ­±³À° 1 : 2018-08-24 0 408 2018-08-22
447 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø À̺ñÀÎÈÄ°ú ±Ý¿äÁý´ãȸ : 2018-09-21 0 665 2018-08-15
446 °æ±â ÇѸ²´ë ÆòÃ̼º½Éº´¿ø ´ëÇÑ°£ÇÐȸ Extrahepatic manifestation of HBV, HBV integration: global pattern and biological function : 2018-09-20 0 4,824 2018-08-15
445 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø Á¦17Â÷ ´ëÇÑ¿¬ÇÏÀå¾ÖÇÐȸ Á¤±âÁý´ãȸ : 2018-09-19 0 964 2018-08-15
444 ¼­¿ï ´ëÇÑ°³¿ø¿µ»óÀÇÇаúÀÇ»çȸ Á¦20Â÷ °ËÁø Çмú´ëȸ ¹× Á¦15Â÷ ÃÊÀ½ÆÄ¿¬¼ö±³À° : 2018-09-16 0 1,152 2018-08-15
443 ¼­¿ï °Ç±¹´ëº´¿ø Á¦5Â÷ ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ °üÀýÃÊÀ½ÆÄ ¿öÅ©¼ó : 2018-09-16 0 770 2018-08-15
442 ¼­¿ï ´ëÇÑÄ¡¸ÅÇÐȸ 2018 Ãß°è º¸¼ö±³À° : 2018-09-16 0 832 2018-08-15
441 ¿ï»ê Á¦5ȸ ¿ï»ê´ëÇб³º´¿ø ¼ÒÈ­±â³»°ú ¿¬¼ö°­Á : 2018-09-15 0 1,362 2018-08-15
440 Á¦ÁÖ ´ëÇÑÄ¡·áÃÊÀ½ÆÄÇÐȸ Á¦4ȸ Á¤±âÇмú´ëȸ : 2018-09-15 0 1,441 2018-08-15
439 ¼­¿ï Á¦74Â÷ ´ëÇÑ¿µ»óÀÇÇÐȸ Çмú´ëȸ(KCR 2018) 4ÀÏÂ÷ : 2018-09-15 0 1,491 2018-08-15
438 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø Çѱ¹½Å°æ¾È°úÇÐȸ Á¤±â½ÉÆ÷Áö¾ö : 2018-09-15 0 801 2018-08-15
1381 | 1382 | 1383 | 1384 | 1385 | 1386 | 1387 | 1388 | 1389 | 1390
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷